USP San Jaime brings leading European breast cancer experts in Alicante
-the VI meeting of breast cancer, which organized jointly the Oncology platform of USP San Jaime, from the hand of the Tedeca Foundation, and the European Institute of Oncology in Milan, will be held on 30 September
-Will be announced the results of 10 years of Oncology platform in the treatment of metastatic, localized breast cancer in high-risk patients
Alicante, September of 2011- the platform of Oncology of the Hospital USP San Jaime (Torrevieja-Alicante) meet on September 30 in Alicante to some of the greatest experts in breast cancer of Europe, in the sixth edition of its meeting technical advances in diagnosis and treatment of breast cancer. The seminar, organized jointly with the European Institute of Oncology (Milan) will bring together more than 200 specialists and she will address advances in prevention, diagnosis and treatment of breast cancer of two centres in the last year
The meeting will include the participation of rapporteurs for important clinical and academic in the field of breast disease and in his course, Oncology platform presented the results of its experience since its inception launched 10 years ago.
Since the year 2000, the Oncology platform has treated approximately 400 patients that they provided the most up-to-date diagnostic techniques and interdisciplinary diagnostic treatment individualized, achieving survival rates higher than those described in the medical literature and registered by some schools internationally recognized.
The USP San Jaime Oncology platform is a centre of reference in the diagnosis and treatment of cancer. It comes to breast cancer, Oncology platform stands for the bet by innovations therapeutical radiotherapy Intraoperatoria, the therapy One Step (which seeks to apply the maximum possible treatment between anaesthesia and the awakening), the creation of a support group for patients of breast and the programme for the care of the cancer in high-risk patientsIt will be presented at the meeting. The Oncology platform performs all these advances in the hands of the Tedeca Foundation, an organization non-profit whose aim is to provide the latest scientific and technological advances for cancer patients treated in the Oncology platform.
The meeting, which this year moved to the headquarters of the College of physicians of Alicante, is aimed at professionals directly or indirectly involved in the prevention, diagnosis and treatment of breast cancer (surgeons, gynecologists, oncologists, radiation, nuclear doctors, plastic surgeons)(, radiologists, psicooncólogos, family, nursing staff physicians, residents and medical students).
On the Foundation Tedeca
The USP San Jaime Oncology platform develops all its care progress hand in hand with the Tedeca Foundation, a non-profit organization created in 1999, integrated in the platform for Oncology and domiciled in the Hospital USP San Jaime (Torrevieja-Alicante). The Foundation, directed by Dr. Antonio Brugarolas, provides the latest scientific and technological advances in cancer patients treated in the Oncology platform, reference Center specializing in the development and application of new technical diagnóstico-terapéuticas of cancer. The Oncology platform constitutes one organizational model in Spain, in which the cancer patient and their needs is focus around which work a team of first level.
About USP hospital
Founded in 1998 and headquartered in Madrid, USP hospital is the first hospital private group in the Spanish market. Currently, USP hospital boasts a network of 12 hospitals, 23 health centres and 4,000 doctors annually serving more than two million patients. In 2010 the company recorded 331.494 clinical stays, 118.931 surgery, 11.202 births and 424.511 er.
On the European Institute of Oncology (IEO)
The IEO is a cancer centres of more relevance in Europe. Headquartered in Milan, it’s an international centre of reference for the cancer patient and for the further training of specialists. The relevant contributions of the IEO in the treatment of breast cancer have turned him into a worldwide reference.